[Practice guideline by the German Society for Pediatric Infectious Diseases with respect to prevention of RSV infections through immunoglobulin administration].
Forster
J
J
Sankt-Josef-Krankenhaus, Freiburg.
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D002648:Child; D006801:Humans; D000069455:Palivizumab; D018357:Respiratory Syncytial Virus Infections / Q000517:prevention & control*; D012136:Respiratory Syncytial Viruses
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069455:Palivizumab
Stellungnahme der Deutschen Gesellschaft für Pädiatrische Infektiologie zur Prophylaxe von RSV-Erkrankungen durch Immunglobuline.